M. Brambilla

1813eP Circulating tumor cells (CTC) characterization in locally advanced non-small cell lung cancer (LA-NSCLC) patients undergoing platinum-based neoadjuvant chemotherapy (pb-NACT)

T. Beninato, Rita Leporati, M. Meazza Prina, L. Mazzeo et autres

it (code pays fourni par la source)

26P: Assessing first-line immunotherapy duration in advanced NSCLC

Simone Rota, R. Serino, P. Ambrosini, T. Beninato et autres

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)

Claudia Proto, M. Ganzinelli, Sara Manglaviti, Martina Imbimbo et autres

it, ch, us (code pays fourni par la source)

1355P Evaluation of the role of variant allele frequency in EGFR mutated non-small cell lung cancer treated with first line osimertinib

M. Brambilla, Daniele Lorenzini, Mario Occhipinti, Sara Manglaviti et autres

it (code pays fourni par la source)

1057P Baseline circulating immature neutrophils anticipate hyperprogressive disease (HPD) upon 1st-line PD-1/PD-L1 inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients (pts) and are reduced by platinum-based chemotherapy (PCT) and ICI combinations

Roberto Ferrara, Giuseppe Lo Russo, Chiara Maura Ciniselli, Settimio Di Gregorio et autres

it, us (code pays fourni par la source)

1071P Trustworthy artificial intelligence models using real-world and circulating genomics data for the prediction of immunotherapy efficacy in non-small cell lung cancer patients

Arsela Prelaj, Achille Bottiglieri, Leonardo Provenzano, A. Spagnoletti et autres

it, us (code pays fourni par la source)

1079P Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with novel actionable oncogenic driver alterations

Teresa Beninato, M. Brambilla, Chiara Pircher, Laura Mazzeo et autres

it, us (code pays fourni par la source)

1056P KRAS and LKB1 mutation conferring prognostic and predictive role on liquid biopsy in advanced NSCLC

A. Bottiglieri, Leonardo Provenzano, A. Spagnoletti, Laura Mazzeo et autres

it, us (code pays fourni par la source)

Are antineoplastic drug acute hypersensitive reactions a submerged or an emergent problem? Experience of the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori.

L. Ferrari, Giuseppe Fanetti, Fabio G. Rossi, M. Brambilla et autres

it (code pays fourni par la source)

Are Antineoplastic Drug Acute Hypersensitive Reactions a Submerged or an Emergent Problem? Experience of the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori

L. Ferrari, Giuseppe Fanetti, Fabio G. Rossi, M. Brambilla et autres

it (code pays fourni par la source)

[Comparison of steady state pharmacokinetics of isosorbide-5-mononitrate in microgranular formulation or hydrophilic matrix].

F Centonze, M. Brambilla, P Pittana, G. C. SERRA et autres

Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C

Fabrizio Villani, Roberto Comazzi, Gemma Lacaita, Antonio Guindani et autres

it (code pays fourni par la source)